RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis

[1] Drilon A(2013)Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas Cancer Discov 3 630-635

[2] Wang L(2008)Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer Clin Cancer Res 14 4751-4757

[3] Hasanovic A(2013)A patient with lung adenocarcinoma and RET fusion treated with vandetanib J Thorac Oncol 8 e43-e44

[4] Suehara Y(1990)PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas Cell 60 557-563

[5] Lipson D(1999)Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system J Clin Oncol 17 1983-1987

[6] Stephens PJ(2012)A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing Genome Res 22 436-445

[7] Ross J(2006)Structure and chemical inhibition of the RET tyrosine kinase domain J Biol Chem 281 33577-33587

[8] Miller VA(2012)KIF5B-RET fusions in lung adenocarcinoma Nat Med 18 375-377

[9] Ginsberg MS(2008)EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer Clin Cancer Res 14 4275-4283

[10] Zakowski MF(2010)Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693-1703

[1] Drilon A(2013)Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas Cancer Discov 3 630-635

[2] Wang L(2008)Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer Clin Cancer Res 14 4751-4757

[3] Hasanovic A(2013)A patient with lung adenocarcinoma and RET fusion treated with vandetanib J Thorac Oncol 8 e43-e44

[4] Suehara Y(1990)PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas Cell 60 557-563

[5] Lipson D(1999)Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system J Clin Oncol 17 1983-1987

[6] Stephens PJ(2012)A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing Genome Res 22 436-445

[7] Ross J(2006)Structure and chemical inhibition of the RET tyrosine kinase domain J Biol Chem 281 33577-33587

[8] Miller VA(2012)KIF5B-RET fusions in lung adenocarcinoma Nat Med 18 375-377

[9] Ginsberg MS(2008)EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer Clin Cancer Res 14 4275-4283

[10] Zakowski MF(2010)Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693-1703